<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:ac46a9e3-9635-4953-9425-e2cd4b86d4b5,g:19d7b680-4e5b-4fbc-892e-e7b2e0383fd4,d:cab50a5ea6444025ac9cb7e23794138b--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>angn-20220609</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl80L2ZyYWc6NjE0NzMyMWU5NGFkNDBmNzkyZGU5Y2M3NjZmODgyYmYvdGFibGU6MGZlNDJlYWFkMWJlNGVjNmFkMjBlYWUxY2JiNWEzZGEvdGFibGVyYW5nZTowZmU0MmVhYWQxYmU0ZWM2YWQyMGVhZTFjYmI1YTNkYV8yLTEtMS0xLTU1MTIz_3794cf47-5c77-45c5-9520-f4da3578d046">0001601485</ix:nonNumeric><ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl80L2ZyYWc6NjE0NzMyMWU5NGFkNDBmNzkyZGU5Y2M3NjZmODgyYmYvdGFibGU6MGZlNDJlYWFkMWJlNGVjNmFkMjBlYWUxY2JiNWEzZGEvdGFibGVyYW5nZTowZmU0MmVhYWQxYmU0ZWM2YWQyMGVhZTFjYmI1YTNkYV81LTEtMS0xLTU1MTIz_d3b1b31a-b188-40f0-a822-9b82a9f7f92d">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="angn-20220609.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-16</xbrli:startDate><xbrli:endDate>2022-05-16</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="icab50a5ea6444025ac9cb7e23794138b_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl8xL2ZyYWc6NzJhYTM0MTI3Yzc1NDA2MDhmOTRmMWM3MjQyMjhiZTQvdGV4dHJlZ2lvbjo3MmFhMzQxMjdjNzU0MDYwOGY5NGYxYzcyNDIyOGJlNF8xNTc2_174d4557-a3f7-4faa-9020-c0373cd6525c">8-K</ix:nonNumeric> </span></div><div style="margin-top:12pt;padding-left:108pt;padding-right:108pt;text-align:center"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:1pt;text-align:center"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date of Report (date of earliest event reported): <ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl8xL2ZyYWc6NzJhYTM0MTI3Yzc1NDA2MDhmOTRmMWM3MjQyMjhiZTQvdGV4dHJlZ2lvbjo3MmFhMzQxMjdjNzU0MDYwOGY5NGYxYzcyNDIyOGJlNF8yMjY_7561caab-6d26-405b-a8fc-2769264b76c9">June 9, 2022</ix:nonNumeric> </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl8xL2ZyYWc6NzJhYTM0MTI3Yzc1NDA2MDhmOTRmMWM3MjQyMjhiZTQvdGV4dHJlZ2lvbjo3MmFhMzQxMjdjNzU0MDYwOGY5NGYxYzcyNDIyOGJlNF8xNTY0_e3bce539-eeca-48dd-9843-bf48ce35bca6">ANGION BIOMEDICA CORP.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl8xL2ZyYWc6NzJhYTM0MTI3Yzc1NDA2MDhmOTRmMWM3MjQyMjhiZTQvdGFibGU6Yjk1ZmU3MDg3NWJjNDNlNGIwMTgyYmE4MGJmYTQ5MDQvdGFibGVyYW5nZTpiOTVmZTcwODc1YmM0M2U0YjAxODJiYTgwYmZhNDkwNF8wLTAtMS0xLTU1MTIz_ee28caba-c3a4-4480-996d-8629b44c316e">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl8xL2ZyYWc6NzJhYTM0MTI3Yzc1NDA2MDhmOTRmMWM3MjQyMjhiZTQvdGFibGU6Yjk1ZmU3MDg3NWJjNDNlNGIwMTgyYmE4MGJmYTQ5MDQvdGFibGVyYW5nZTpiOTVmZTcwODc1YmM0M2U0YjAxODJiYTgwYmZhNDkwNF8wLTEtMS0xLTU1MTIz_446ac4a9-cf2a-4c4d-99f7-7966b114a5b4">001-39990</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl8xL2ZyYWc6NzJhYTM0MTI3Yzc1NDA2MDhmOTRmMWM3MjQyMjhiZTQvdGFibGU6Yjk1ZmU3MDg3NWJjNDNlNGIwMTgyYmE4MGJmYTQ5MDQvdGFibGVyYW5nZTpiOTVmZTcwODc1YmM0M2U0YjAxODJiYTgwYmZhNDkwNF8wLTItMS0xLTU1MTIz_f802c958-2c9a-4377-b4dd-7a31475cf04d">11-3430072</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></div></td></tr><tr style="height:14pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl8xL2ZyYWc6NzJhYTM0MTI3Yzc1NDA2MDhmOTRmMWM3MjQyMjhiZTQvdGFibGU6Yjk1ZmU3MDg3NWJjNDNlNGIwMTgyYmE4MGJmYTQ5MDQvdGFibGVyYW5nZTpiOTVmZTcwODc1YmM0M2U0YjAxODJiYTgwYmZhNDkwNF8zLTEtMS0xLTU1MTIz_af0aa215-8c39-4f3e-a6a4-a519dadab077">51 Charles Lindbergh Boulevard</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl8xL2ZyYWc6NzJhYTM0MTI3Yzc1NDA2MDhmOTRmMWM3MjQyMjhiZTQvdGFibGU6Yjk1ZmU3MDg3NWJjNDNlNGIwMTgyYmE4MGJmYTQ5MDQvdGFibGVyYW5nZTpiOTVmZTcwODc1YmM0M2U0YjAxODJiYTgwYmZhNDkwNF80LTEtMS0xLTU1MTIzL3RleHRyZWdpb246MDE3YTAwYWQ3YjZlNGIwYzkxY2RjODg5ZGY3YmUzZmVfNA_2c9db028-8d93-4651-a772-ae15b77965ab">Uniondale</ix:nonNumeric>,  <ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl8xL2ZyYWc6NzJhYTM0MTI3Yzc1NDA2MDhmOTRmMWM3MjQyMjhiZTQvdGFibGU6Yjk1ZmU3MDg3NWJjNDNlNGIwMTgyYmE4MGJmYTQ5MDQvdGFibGVyYW5nZTpiOTVmZTcwODc1YmM0M2U0YjAxODJiYTgwYmZhNDkwNF80LTEtMS0xLTU1MTIzL3RleHRyZWdpb246MDE3YTAwYWQ3YjZlNGIwYzkxY2RjODg5ZGY3YmUzZmVfOA_37f351e9-eb72-4237-ae2f-f21559d5f153">New York</ix:nonNumeric> <ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl8xL2ZyYWc6NzJhYTM0MTI3Yzc1NDA2MDhmOTRmMWM3MjQyMjhiZTQvdGFibGU6Yjk1ZmU3MDg3NWJjNDNlNGIwMTgyYmE4MGJmYTQ5MDQvdGFibGVyYW5nZTpiOTVmZTcwODc1YmM0M2U0YjAxODJiYTgwYmZhNDkwNF80LTEtMS0xLTU1MTIzL3RleHRyZWdpb246MDE3YTAwYWQ3YjZlNGIwYzkxY2RjODg5ZGY3YmUzZmVfMTE_3c4f6d2e-edcf-47d6-910b-e96b6c5f4101">11553</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices, including zip code )</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl8xL2ZyYWc6NzJhYTM0MTI3Yzc1NDA2MDhmOTRmMWM3MjQyMjhiZTQvdGV4dHJlZ2lvbjo3MmFhMzQxMjdjNzU0MDYwOGY5NGYxYzcyNDIyOGJlNF8xNTY1_6c3d9a42-713c-40e1-82e5-d9ff45d2fbc5">415</ix:nonNumeric>) <ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl8xL2ZyYWc6NzJhYTM0MTI3Yzc1NDA2MDhmOTRmMWM3MjQyMjhiZTQvdGV4dHJlZ2lvbjo3MmFhMzQxMjdjNzU0MDYwOGY5NGYxYzcyNDIyOGJlNF8xNTY2_e800645d-38f5-442c-9712-019ca0753165">655-4899</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:WrittenCommunications" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl8xL2ZyYWc6NzJhYTM0MTI3Yzc1NDA2MDhmOTRmMWM3MjQyMjhiZTQvdGV4dHJlZ2lvbjo3MmFhMzQxMjdjNzU0MDYwOGY5NGYxYzcyNDIyOGJlNF8xNTcy_65ecb7ee-e051-4931-a5e6-2b5da8959bc0">&#9744;</ix:nonNumeric> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl8xL2ZyYWc6NzJhYTM0MTI3Yzc1NDA2MDhmOTRmMWM3MjQyMjhiZTQvdGV4dHJlZ2lvbjo3MmFhMzQxMjdjNzU0MDYwOGY5NGYxYzcyNDIyOGJlNF8xNTcz_d628e149-35c9-43d6-84c0-054249189a51">&#9744;</ix:nonNumeric> </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl8xL2ZyYWc6NzJhYTM0MTI3Yzc1NDA2MDhmOTRmMWM3MjQyMjhiZTQvdGV4dHJlZ2lvbjo3MmFhMzQxMjdjNzU0MDYwOGY5NGYxYzcyNDIyOGJlNF8xNTY4_82bc1d97-928e-45b3-8634-dfc1158c304e">&#9744;</ix:nonNumeric> </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl8xL2ZyYWc6NzJhYTM0MTI3Yzc1NDA2MDhmOTRmMWM3MjQyMjhiZTQvdGV4dHJlZ2lvbjo3MmFhMzQxMjdjNzU0MDYwOGY5NGYxYzcyNDIyOGJlNF8xNTc0_775e98c6-7bd3-482b-9e69-75aa9f120cee">&#9744;</ix:nonNumeric></span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Title of each class)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Trading Symbol)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Name of exchange on which registered)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl8xL2ZyYWc6NzJhYTM0MTI3Yzc1NDA2MDhmOTRmMWM3MjQyMjhiZTQvdGFibGU6ZjgzMWMzZDU3MTg4NGQ0M2IyYWNiYTI3ZDdjN2QwN2YvdGFibGVyYW5nZTpmODMxYzNkNTcxODg0ZDQzYjJhY2JhMjdkN2M3ZDA3Zl8xLTAtMS0xLTU1MTIz_75979731-73dc-49f8-a504-3ed02a93f927">Common Stock</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl8xL2ZyYWc6NzJhYTM0MTI3Yzc1NDA2MDhmOTRmMWM3MjQyMjhiZTQvdGFibGU6ZjgzMWMzZDU3MTg4NGQ0M2IyYWNiYTI3ZDdjN2QwN2YvdGFibGVyYW5nZTpmODMxYzNkNTcxODg0ZDQzYjJhY2JhMjdkN2M3ZDA3Zl8xLTEtMS0xLTU1MTIz_1d4e0d3f-4fe4-4b8b-964d-ec82c0e092a5">ANGN</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl8xL2ZyYWc6NzJhYTM0MTI3Yzc1NDA2MDhmOTRmMWM3MjQyMjhiZTQvdGFibGU6ZjgzMWMzZDU3MTg4NGQ0M2IyYWNiYTI3ZDdjN2QwN2YvdGFibGVyYW5nZTpmODMxYzNkNTcxODg0ZDQzYjJhY2JhMjdkN2M3ZDA3Zl8xLTItMS0xLTU1MTIz_1d94a188-48be-4be5-8fcd-2ce2417f4cd9">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl8xL2ZyYWc6NzJhYTM0MTI3Yzc1NDA2MDhmOTRmMWM3MjQyMjhiZTQvdGV4dHJlZ2lvbjo3MmFhMzQxMjdjNzU0MDYwOGY5NGYxYzcyNDIyOGJlNF8xMzA3_3464d2f9-5cbe-4031-98e0-772793cd37c3">&#9746;</ix:nonNumeric></span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d8689ff959e4adb88b313c390889f21_D20220516-20220516" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmNhYjUwYTVlYTY0NDQwMjVhYzljYjdlMjM3OTQxMzhiL3NlYzpjYWI1MGE1ZWE2NDQ0MDI1YWM5Y2I3ZTIzNzk0MTM4Yl8xL2ZyYWc6NzJhYTM0MTI3Yzc1NDA2MDhmOTRmMWM3MjQyMjhiZTQvdGV4dHJlZ2lvbjo3MmFhMzQxMjdjNzU0MDYwOGY5NGYxYzcyNDIyOGJlNF8xNTcw_0a9e27ec-ec3f-4f5e-a5dc-7db34ff9fe4c">o</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="icab50a5ea6444025ac9cb7e23794138b_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.07. Submission of Matters to a Vote of Security Holders</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">June&#160;9, 2022</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Angion Biomedica Corp., held its 2022 Annual Meeting of Stockholders. The following is a brief description of each matter voted upon at the Annual Meeting, as well as the final tally of the number of votes cast: (a) for or withheld with respect to the election of directors; and (b) for, against or abstain for the ratification of the appointment of Moss Adams LLP as Angion&#8217;s independent registered public accounting firm for the fiscal year ending December&#160;31, 2022.  Broker non-votes are also reported. A more complete description of each matter is set forth in Angion&#8217;s proxy statement, filed with the Securities and Exchange Commission on April 27, 2022.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="padding-left:58.5pt;text-indent:-58.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Proposal 1:   Each of the two directors proposed by Angion for re-election was elected to serve until Angion&#8217;s 2025 Annual Meeting of Stockholders or until his or her respective successor has been elected and qualified. The tabulation of votes on this matter was as follows: </span></div><div style="padding-left:58.5pt;text-indent:-58.5pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.760%"><tr><td style="width:1.0%"></td><td style="width:34.023%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.802%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broker</span></td></tr><tr style="height:16pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Withheld</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Votes</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jay R. Venkatesan, M.D.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,475,236</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,495,011</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,689,515</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Karen J. Wilson</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,419,646</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,550,601</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,689,515</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:58.5pt;text-indent:-58.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Proposal 2:   The appointment of Moss Adams LLP as Angion&#8217;s independent registered public accounting firm for the fiscal year ending December&#160;31, 2022, was ratified. The tabulation of votes on this matter was as follows: </span></div><div style="padding-left:108pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:47.222%"><tr><td style="width:1.0%"></td><td style="width:27.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.790%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Broker</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Abstain</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Non-Votes</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20,658,864</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">527</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">371</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0</span></td></tr></table></div><div id="icab50a5ea6444025ac9cb7e23794138b_16"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:10pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.578%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ANGION BIOMEDICA CORP.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">/s/ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Jennifer J. Rhodes</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">June 13, 2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Jennifer J. Rhodes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">EVP, CBO and General Counsel</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "angn-20220609.htm", "description": "8-K", "secsgml_size_bytes": 36866}]
{"company-data": {"conformed-name": "Angion Biomedica Corp.", "cik": "0001601485", "assigned-sic": "2834", "irs-number": "113430072", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-39990", "film-number": "221013047"}, "business-address": {"street1": "51 CHARLES LINDBERGH BOULEVARD", "city": "UNIONDALE", "state": "NY", "zip": "11553", "phone": "(415) 655-4899"}, "mail-address": {"street1": "51 CHARLES LINDBERGH BOULEVARD", "city": "UNIONDALE", "state": "NY", "zip": "11553"}}
angn-20220609
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (date of earliest event reported):
June 9, 2022
ANGION BIOMEDICA CORP.
(Exact name of registrant as specified in its charter)
Delaware
001-39990
11-3430072
(State or other jurisdiction of incorporation or organization)
(Commission File Number)
(IRS Employer Identification No.)
51 Charles Lindbergh Boulevard
Uniondale
,
New York
11553
(Address of principal executive offices, including zip code )
(
415
)
655-4899
Registrant's telephone number, including area code
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
(Title of each class)
(Trading Symbol)
(Name of exchange on which registered)
Common Stock
ANGN
The Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o
Item 5.07. Submission of Matters to a Vote of Security Holders
On
June 9, 2022
, Angion Biomedica Corp., held its 2022 Annual Meeting of Stockholders. The following is a brief description of each matter voted upon at the Annual Meeting, as well as the final tally of the number of votes cast: (a) for or withheld with respect to the election of directors; and (b) for, against or abstain for the ratification of the appointment of Moss Adams LLP as Angion's independent registered public accounting firm for the fiscal year ending December 31, 2022.  Broker non-votes are also reported. A more complete description of each matter is set forth in Angion's proxy statement, filed with the Securities and Exchange Commission on April 27, 2022.
Proposal 1:   Each of the two directors proposed by Angion for re-election was elected to serve until Angion's 2025 Annual Meeting of Stockholders or until his or her respective successor has been elected and qualified. The tabulation of votes on this matter was as follows:
Broker
For
Withheld
Non-Votes
Jay R. Venkatesan, M.D.
12,475,236
2,495,011
5,689,515
Karen J. Wilson
12,419,646
2,550,601
5,689,515
Proposal 2:   The appointment of Moss Adams LLP as Angion's independent registered public accounting firm for the fiscal year ending December 31, 2022, was ratified. The tabulation of votes on this matter was as follows:
Broker
For
Against
Abstain
Non-Votes
20,658,864
527
371
0
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ANGION BIOMEDICA CORP.
By:
/s/
Jennifer J. Rhodes
Date:
June 13, 2022
Jennifer J. Rhodes
EVP, CBO and General Counsel